Look at that Liquidation Process. I guess that liquidation scenario came true.
“These assets comprise ALL the companies assets save and except for the cash, accounts receivable, and inventory of the company and also excluded certain US based office equipment”
Well look at that all of the assets sold to LCYB after all lol
“BioAmber Provides Update on Liquidation Process”
“On October 22, 2018, the Company completed the sale of certain of its assets to LCY Biotechnology Inc. (previously 9384-3076 Québec Inc.). These assets comprised all of the Company’s assets, save and except for the cash, accounts receivable and inventory of the Company, and also excluded certain U.S. based office equipment. The purchaser did not seek the assignment of the Company’s contracts, which meant that certain intellectual property under license from third parties was also not transferred to the purchaser.
This transaction was approved by the Quebec Superior Court of Justice on September 18, 2018, and by the United States Bankruptcy Court for the District of Delaware on October 9, 2018.
The liquidation of the Company’s assets will result in little to no residual value for non-secured creditors, and no residual value for equity investors of the Company.”
Directly from BioAmber’s own 8k SEC filing and coincidentally that was the last 8k to ever be filed.
News 
Market Data 
Discover 
